logo
logo

Glytec Raises $21 Million To Set The Standard For Hospital Insulin Dosing And Glycemic Management

Apr 26, 2021•about 4 years ago

Amount Raised

$21 Million

WalthamHospitals and Health Care

Description

Glytec, the only provider of insulin management software across the continuum of care, today announced $21 million in financing from Silicon Valley Bank (SVB), Savitr Capital and other private investors. The funding will fuel Glytec’s mission of revolutionizing the role glycemic management plays in the hospital across every department. The combined $9 million debt financing from SVB and $12 million equity investment led by Savitr positions the company to continue its rapid growth by investing in research and development around patient safety, provider workflows and analytics, adding additional talent to its workforce and enhancing integrations with EHRs, mobile apps and other diabetes technology across the continuum of care.

Company Information

Company

Glytec

Location

Waltham, Massachusetts, United States

About

Glytec is the insulin management software company for healthcare systems focused on improving the quality and cost of care. Its FDA-cleared proprietary algorithmic titration software, Glucommander, as well as innovative analytics tools like Glucometrics power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its nationwide team of clinicians, health system leaders, and technologists in offices located in Waltham, MA, and Greenville, SC, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People